FeaturedNeurology·March 29, 2017·7 min readNew Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt DiseaseFDA approves a new drug to treat both relapsing-remitting multiple sclerosis and primary progressive MS.Read More